NCT05202275 2022-01-21
The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
ChineseAMS
Phase 2 Unknown
Clinical Trials
9 trialsNCT04430361 2020-06-12
the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
Henan Cancer Hospital
Phase 2 Unknown
NCT03679182 2018-09-20
Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care
Khon Kaen University
Phase 2 Unknown
NCT02445872 2015-12-09
Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy
Zhejiang University
Phase 2 Unknown
NCT02407600 2015-04-03
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
State University of New York - Upstate Medical University
Phase 2 Unknown
NCT01788605 2014-12-08
Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation
The Catholic University of Korea
Phase 2 Unknown
NCT02290470 2014-11-14
Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT02234466 2014-09-09
Preoperative Oral Dexamethasone to Improve Recovery After Surgery
University of Manitoba
Phase 2 Unknown
NCT01046461 2012-02-17
RAD
Hallym University Medical Center
Phase 2 Unknown